Medtronic PLC (XETRA:2M6) — Market Cap & Net Worth
Market Cap & Net Worth: Medtronic PLC (2M6)
Medtronic PLC (XETRA:2M6) has a market capitalization of $83.04 Billion (€71.03 Billion) as of August 1, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #314 globally and #60 in its home market, demonstrating a -1.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medtronic PLC's stock price €69.20 by its total outstanding shares 1283884964 (1.28 Billion). See Medtronic PLC capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
Medtronic PLC Market Cap History: 2015 to 2026
Medtronic PLC's market capitalization history from 2015 to 2026. Data shows growth from $82.41 Billion to $110.38 Billion (3.00% CAGR).
Medtronic PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medtronic PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.04x
Medtronic PLC's market cap is 3.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.00x
Medtronic PLC's market cap is 23.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $83.45 Billion | $29.71 Billion | $4.03 Billion | 2.81x | 20.72x |
| 2018 | $98.55 Billion | $29.95 Billion | $3.10 Billion | 3.29x | 31.75x |
| 2019 | $130.74 Billion | $30.56 Billion | $4.63 Billion | 4.28x | 28.23x |
| 2020 | $125.33 Billion | $28.91 Billion | $4.79 Billion | 4.33x | 26.17x |
| 2021 | $125.97 Billion | $30.12 Billion | $3.61 Billion | 4.18x | 34.93x |
| 2022 | $102.29 Billion | $31.69 Billion | $5.04 Billion | 3.23x | 20.30x |
| 2023 | $109.07 Billion | $31.23 Billion | $3.76 Billion | 3.49x | 29.02x |
| 2024 | $115.67 Billion | $32.36 Billion | $3.68 Billion | 3.57x | 31.47x |
| 2025 | $123.47 Billion | $33.54 Billion | $4.66 Billion | 3.68x | 26.48x |
| 2026 | $110.38 Billion | $36.36 Billion | $4.80 Billion | 3.04x | 23.00x |
Competitor Companies of 2M6 by Market Capitalization
Companies near Medtronic PLC in the global market cap rankings as of August 1, 2026.
Key companies related to Medtronic PLC by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #402 globally with a market cap of $69.46 Billion USD.
- Edwards Lifesciences Corp (NYSE:EW): Ranked #542 globally with a market cap of $49.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #402 | Boston Scientific Corp | NYSE:BSX | $69.46 Billion | $46.73 |
| #542 | Edwards Lifesciences Corp | NYSE:EW | $49.56 Billion | $86.07 |
Medtronic PLC Historical Marketcap From 2015 to 2026
Between 2015 and today, Medtronic PLC's market cap moved from $82.41 Billion to $ 110.38 Billion, with a yearly change of 3.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €110.38 Billion | -10.60% |
| 2025 | €123.47 Billion | +6.75% |
| 2024 | €115.67 Billion | +6.05% |
| 2023 | €109.07 Billion | +6.62% |
| 2022 | €102.29 Billion | -18.80% |
| 2021 | €125.97 Billion | +0.51% |
| 2020 | €125.33 Billion | -4.14% |
| 2019 | €130.74 Billion | +32.66% |
| 2018 | €98.55 Billion | +18.10% |
| 2017 | €83.45 Billion | +2.34% |
| 2016 | €81.54 Billion | -1.06% |
| 2015 | €82.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 13th, 2026 the market cap of Medtronic PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $83.04 Billion USD |
| MoneyControl | $83.04 Billion USD |
| MarketWatch | $83.04 Billion USD |
| marketcap.company | $83.04 Billion USD |
| Reuters | $83.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more